CAMARILLO, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: QBAK), a trusted provider of scalable data storage and high-efficiency power solutions, today reported financial results for the quarter ended December 31, 2025. 2025 and Recent HighlightsWe achieved 9% year-over-year revenue growth in our Data Storage business. We recently launched the Q1000+ Powered by Orion, an enterprise tape library storage solution designed to be Simply Reliable™, offering superior performance and scalability for short-term backup, disaster recovery, and long-term archiving requirements. We hold over $2.8 million in cash, cash equivalents, and marketable securities, with no outstanding debt.Management Commentary “Despite a nearly $1.9 million decline in our Power Supply business and a slower fourth quarter overall,...

Financial Press Release : Annual results 2025   Reims, March 30, 2026 The Board of Directors of Maison Pommery & Associés met on March 30, 2026, under the chairmanship of Mr. Paul François Vranken, and in the presence of the Statutory Auditors, to approve the Group’s financial statements for the 2025 fiscal year.Consolidated data 31/12/2025*(M€) 31/12/2024(M€) Change(M€) Change(%)Turnover 293.2 304.0 -10.8 -3.6%Current Operating Income 20.0 35.7 -15.7 -44.1%Operating Income 64.1 35.1 +29.0 +82.5%Financial Result -32.6 -33.5 -0.9  Net Income 31.9 0.8 +31.0 +3751.9%Attributable to equity holders of the parent 32.0 0.9 +31.1 +3393.9%*The process of auditing and issuing the audit report for the certification of the consolidated accounts is underway. Business activity: market share gains in a contracting market Maison...

Please find attached the annual report (ESEF format) in English, for information only. The French version is the official one.Attachmentsolutions30-2025-12-31-en

2025 Annual Results Strong Revenue Growth in 2025: up 14% with Subscriptions up 20% Record Profitability: EBITDA up 22% to €13.4 million, Representing 22% of Revenue (+2 pts) Operating Leverage Confirmed: Net Profit of €9.0 million, up 14% March 30, 2026 | Sidetrade (Euronext Growth: ALBFR), the AI platform dedicated to Order-to-Cash, today announces its 2025 annual results, achieving a new all-time high in profitability despite a challenging macroeconomic environment: revenue growth of 14% at constant currency (12% on reported basis), EBITDA up 22% to €13.4 million, representing 22% of revenue, and net profit of €9.0 million (14%).Sidetrade (€m) 2025 2024 VariationRevenue 61.4 55.0 +12%of which Subscriptions 53,5 45,5 +18%Gross Margin 47.4 43.1 +10%as a % of Revenue 77% 78%         EBITDA* 13.4 11.0 +22%as a %...

IRVING, Texas, March 30, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. Following the transformative acquisition of Exela Technologies BPA, LLC (“BPA”) in July 2025, the Company is reporting results that reflect a significant transition period. To provide a clearer view of the combined business’ performance, the Company has included pro forma metrics alongside reported GAAP results, with reconciliations to the most comparable GAAP metrics in this release, where applicable. Reported results exclude the results of our European operations (“XBP...

Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma (rrMM) BRISBANE, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today reported financial results for the year ended December 31, 2025, and provided a corporate update. “2025 was a transformative year for Tempest as we strengthened our pipeline with the strategic acquisition of a portfolio of next-generation CAR-T assets,” said Matt Angel, Ph.D., President and Chief...

Reports $46.8M Revenue for 2025 materially ahead of market expectations Exits 2025 at $232M ARR1 with $19.4M December MRR1 Contracted Revenue1 Underpins 2026 Growth Trajectory FY 2026 revenue guidance raised to $360 million; Reiterated 2026 exit ARR1 of $500 million  NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in Agentic Commerce and AI-powered retail infrastructure, today announced its full-year 2025 results, delivering performance materially ahead of market expectations and moving the business into live, scaled global deployment. Record Revenue: Reported GAAP revenue of $46.8 million for the year. Explosive Exit Velocity: Exited 2025 with a record $19.4M December MRR, representing a $232M+ Annualized Run Rate (ARR), exceeding original guidance of $100 million. Structural Profitability:...

Signed First Binding Customer Offtake Agreement with Trafigura Received Indications of Interest for Over $1 Billion in Project Finance Provides an Update on Plans for a Final Investment Decision (“FID”) on the South West Arkansas Project (the “SWA Project”)VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three-month and full year periods ended December 31, 2025. “We had a busy and productive fourth quarter as we advanced and completed multiple important milestones and deliverables for the Company,” said David Park, Chief Executive Officer and Director of Standard Lithium. “We filed a positive Definitive Feasibility Study for...

First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren’s disease $75 million private placement strengthens balance sheet and supports telitacicept global clinical development Pro-forma cash and investment balance of $530.2 million as of December 31, 2025 expected to provide runway into early 2029 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update. “Over the past six months, Vor Bio repositioned the company around telitacicept and moved quickly to build momentum. We are seeing strong engagement from key opinion leaders and principal investigators,...

HANGZHOU, China, March 30, 2026 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider and crypto treasury company today announced its unaudited financial results as of December 31, 2025 and for the six months ended December 31, 2025. Second Half of 2025 Financial SummaryNet revenue increased by 18.1% to RMB18.7 million (US$2.7 million) for the second half of 2025, from RMB15.9 million in the same period of 2024. Gross loss was RMB29.1 million (US$4.1 million) for the second half of 2025, compared to a gross profit of RMB11.6 million in the same period of 2024. Gain on change in fair value of cryptocurrencies was RMB130.0 million (US$18.5 million) for the second half of 2025, compared to a loss of RMB15.7 million in the same period of 2024. Profit...